APPLICATION
ANDA091161
TYPE
ANDA
ORIGINAL APPROVAL
2016-03-22
LATEST ACTION
2024-11-27
ROUTE
NASAL
DOSAGE FORM
SPRAY, METERED
MARKETING STATUS
Prescription
Products
MOMETASONE FUROATEPrescription
MOMETASONE FUROATE 0.05MG/SPRAY · SPRAY, METERED · NASAL
Approval history
2024-11-27Labeling · Supplement 6 · standardAP
2024-11-27Labeling · Supplement 2 · standardAP
2024-11-27Labeling · Supplement 5 · standardAP
2024-11-27Labeling · Supplement 1 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.